Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Liqingtong Granule
- Development stage
- Unknown
- Lead developer
- 983 Hospital of the PLA Joint Service Support Force
- Modality
- Small Molecules
- Administration
- Oral
01
Overview
Liqingtong Granule is a Traditional Chinese Medicine (TCM) in-hospital preparation developed by the 983 Hospital of the PLA Joint Service Support Force (formerly the 272nd Hospital). It is primarily indicated for the treatment of hyperuricemia and gouty arthritis. The formulation is composed of several herbal extracts, including *Smilax glabra*, *Plantago asiatica*, *Dioscorea septemloba*, and *Cyathula officinalis*, which act synergistically to manage urate levels. Its mechanism of action involves the inhibition of xanthine oxidase, thereby reducing the synthesis of uric acid, and the inhibition of renal urate transporters such as URAT1 (SLC22A12), which promotes the excretion of uric acid through the kidneys. Clinical application within the hospital system has shown it to be effective in lowering serum uric acid and reducing the frequency of gout flares with a favorable safety profile.
- Brand names
- Liqingtong Granule
- Other names
- Liqingtong Keli利清通颗粒
02
Targets
XO (Xanthine Oxidoreductase)URAT1 (Uric Acid Transporter 1)
Beyond the preview
Go deeper on Liqingtong Granule.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Liqingtong Granule.